Literature DB >> 29171557

Effects of supervised structured aerobic exercise training programme on level of Exertion, dyspnoea, VO2 max and Body Mass Index in patients with type 2 diabetes mellitus.

Syed Shakil Ur Rehman1, Hossein Karimi2, Syed Amir Gillani3, Shakeel Ahmad4.   

Abstract

OBJECTIVE: To determine the effects of supervised structured aerobic exercise training programme on level of exertion, dyspnoea, maximum oxygen consumption, and body mass index in type 2 diabetics.
METHODS: The randomised, controlled trial was carried out at Riphah Rehabilitation and Research Centre, Islamic International medical College Trust, Pakistan Railways General Hospital, Rawalpindi, Pakistan, from January 2015 to June 2016, and comprised type 2 diabetics. Sedentary individuals of both genders, aged40-70 years, diagnosed on World Health Organisation's criteria were included. Participants were randomly divided into two groups, i.e. A (experimental) and B (control), by toss and trial method. Intervention in the experimental group were supervised structured aerobic exercise training programme, routine medication and dietary, while the control group was treated by routine medication and dietary plan for 25 weeks at 3 days per week for both groups. Level of exertion, dyspnoea, maximum oxygen consumption and body mass index were assessed and documented at baseline (0 week) and at the completion of intervention (after 25 weeks). SPSS20 was used for data analysis.
RESULTS: Of the 102 participants, there were 51(50%) in each group. Pre- and post-intervention analysis showed that a 25-week training programme, routine medication, and dietary plan significantly improved level of exertion, dyspnoea, maximum oxygen consumption and body mass index (p<0.05)) in the experimental group compared to the control group treated with routine medication, and dietary plan.
CONCLUSIONS: The supervised structured aerobic exercise training programme along with routine medication and dietary plan positively influenced level of exertion, dyspnoea, maximum oxygen consumption and body mass index than routine medication and dietary plan in patients with type 2 diabetes.

Entities:  

Keywords:  Aerobic exercise, Level of exertion, Dyspnoea, VO2max, BMI.

Mesh:

Year:  2017        PMID: 29171557

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  5 in total

1.  Anthropometric, Cardiopulmonary and Metabolic Benefits of the High-Intensity Interval Training Versus Moderate, Low-Intensity or Control for Type 2 Diabetes: Systematic Review and Meta-Analysis.

Authors:  Ivan Lora-Pozo; David Lucena-Anton; Alejandro Salazar; Alejandro Galán-Mercant; Jose A Moral-Munoz
Journal:  Int J Environ Res Public Health       Date:  2019-11-15       Impact factor: 3.390

2.  An Endurance-Dominated Exercise Program Improves Maximum Oxygen Consumption, Ground Reaction Forces, and Muscle Activities in Patients With Moderate Diabetic Neuropathy.

Authors:  AmirAli Jafarnezhadgero; Elahe Mamashli; Urs Granacher
Journal:  Front Physiol       Date:  2021-03-18       Impact factor: 4.566

3.  Effectiveness of physical activity counselling provided for people with type 2 diabetes mellitus in primary healthcare in North Karelia, Finland: a register-based evaluation study.

Authors:  Tuula Marketta Martiskainen; Marja-Leena Lamidi; Mika Venojärvi; Heikki Tikkanen; Tiina Laatikainen
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

Review 4.  Lifestyle Interventions to Improve Glycemic Control in Adults with Type 2 Diabetes Living in Low-and-Middle Income Countries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).

Authors:  Grainne O'Donoghue; Cliona O'Sullivan; Isabelle Corridan; Jennifer Daly; Ronan Finn; Kathryn Melvin; Casey Peiris
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

5.  Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach.

Authors:  Lorenzo Nesti; Nicola Riccardo Pugliese; Paolo Sciuto; Andrea Natali
Journal:  Cardiovasc Diabetol       Date:  2020-09-05       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.